Company Overview of Diartis Pharmaceuticals, Inc.
Diartis Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutic proteins for the treatment of metabolic disorders. Its development portfolio includes VRS-859, a glucagon-like peptide-1 analog that provides improved therapeutic outcomes for Type 2 diabetic patients. The company was incorporated in 2010 and is based in Redwood City, California.
275 Shoreline Drive
Redwood City, CA 94065
Founded in 2010
Key Executives for Diartis Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Diartis Pharmaceuticals, Inc., please visit www.diartispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.